The majority of RHO-RP patients are heterozygous carriers, meaning their photoreceptor cells produce both mutated and wild-type proteins at similar transcriptional levels as seen for the knock-in mouse models of adRP [3, 4]. The gene discussed is RHO; the disease is retinitis pigmentosa 1.